Literature DB >> 21535334

Recombinant soluble form of heparin-binding epidermal growth factor-like growth factor protein therapy drastically inhibits Fas-mediated fulminant hepatic failure: Implications in clinical application.

Ngin Cin Khai1, Kouichi Sakamoto, Hideo Takamatsu, Hiroshi Matsufuji, Ken-Ichiro Kosai.   

Abstract

Entities:  

Year:  2011        PMID： 21535334     DOI： 10.1111/j.1872-034X.2011.00805.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN： 1386-6346            Impact factor:   4.288


× No keyword cloud information.
  1 in total

1.  Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms.

Authors:  Kouichi Sakamoto; Ngin Cin Khai; Yuqing Wang; Rie Irie; Hideo Takamatsu; Hiroshi Matsufuji; Ken-Ichiro Kosai
Journal:  Int J Mol Med       Date:  2016-10-20       Impact factor: 4.101
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.